Vimarsana
Biggest News Aggregation in the World

Page 32 - Further Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Further Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Further Information Today - Breaking & Trending Today

Logicmojo Data Science Course To Become Data Scientist in 2024 - Vimarsana News

Logicmojo Data Science Course To Become Data Scientist in 2024

The Logicmojo Data Science Course & Bootcamp is set to commence in 2024.

Canadian Gold Corp. Highlights Transformative 2023 for Shareholders - Vimarsana News

Canadian Gold Corp. Highlights Transformative 2023 for Shareholders

Canadian Gold Corp. is pleased to announce a summary of the work completed in 2023, in what has been a transformative year, and in addition, presents the Company's early exploration and development...

Endeavour Silver Announces At-the-Market Offering of up to US$60 Million - Vimarsana News

Endeavour Silver Announces At-the-Market Offering of up to US$60 Million

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Endeavour Silver Announces At-the-Market Offering of up to - Vimarsana News

Endeavour Silver Announces At-the-Market Offering of up to

VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) announces it...

Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer's Disease -December 19, 2023 at 07:31 am EST - Vimarsana News

Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer's Disease -December 19, 2023 at 07:31 am EST

NEW YORK, Dec. 19, 2023 -- Anavex Life Sciences Corp. , a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and...